Cancer Incidence Trends in the Oil Shale Industrial Region in Estonia.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
28 05 2020
Historique:
received: 01 04 2020
revised: 15 05 2020
accepted: 23 05 2020
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 6 11 2020
Statut: epublish

Résumé

Large oil shale resources are found in Eastern Estonia, where the mineral resource is mined, excavated, and used for electricity generation and shale oil extraction. During industrial activities in the last 100 years, pollutants have been emitted in large amounts, some of which are toxic and carcinogenic. The current study aims to analyse time trends in cancer incidence in the oil shale industry-affected areas and compare them with overall cancer incidence rates and trends in Estonia. We analysed Estonian Cancer Registry data on selected cancer sites that have been previously indicated to have relationships with industrial activities like oil shale extraction. We included lung cancer, kidney cancer, urinary bladder cancer, leukaemia, breast cancer, and non-Hodgkin's lymphoma. A statistically significantly higher lung cancer age-standardized incidence rate (ASIR) was found during the study period (1992-2015) only in males in the oil shale areas as compared to males in Estonia overall: 133.6 and 95.5 per 100,000, respectively. However, there appeared to be a statistically significant (

Identifiants

pubmed: 32481656
pii: ijerph17113833
doi: 10.3390/ijerph17113833
pmc: PMC7312168
pii:
doi:

Substances chimiques

Minerals 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Lancet Oncol. 2017 Dec;18(12):1574-1575
pubmed: 29107678
IARC Sci Publ. 1990;(104):354-62
pubmed: 2228133
Environ Health Perspect. 1979 Jun;30:209-10
pubmed: 446453
Environ Int. 2011 Apr;37(3):577-85
pubmed: 21216467
Environ Res. 2017 Nov;159:555-563
pubmed: 28889025
Sci Total Environ. 2004 Apr 25;322(1-3):41-50
pubmed: 15081736
J Environ Radioact. 2017 Jan;166(Pt 2):235-241
pubmed: 27554705
Thorax. 2006 Dec;61(12):1076-82
pubmed: 17040935
Occup Environ Med. 2018 Sep;75(9):617-622
pubmed: 29705772
Int J Epidemiol. 2009 Apr;38(2):512-25
pubmed: 19052117
Annu Rev Public Health. 2008;29:75-90
pubmed: 17914933
Front Oncol. 2018 Jun 13;8:151
pubmed: 29951370
Evol Appl. 2017 Aug 24;11(2):140-152
pubmed: 29387151
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Epidemiol Prev. 2018 Sep-Dec;42(5-6S1):76-85
pubmed: 30322238
Am J Ind Med. 1986;9(5):433-46
pubmed: 3717168
Mutat Res. 2005 Jun 6;583(2):120-32
pubmed: 15876548
J Environ Public Health. 2013;2013:753719
pubmed: 24454414
IARC Monogr Eval Carcinog Risk Chem Hum. 1985 Jan;35:1-247
pubmed: 2991123
Sci Total Environ. 2019 Feb 10;650(Pt 1):65-72
pubmed: 30195132
Ann Epidemiol. 2003 Aug;13(7):485-94
pubmed: 12932623
Int J Hyg Environ Health. 2018 Mar;221(2):308-314
pubmed: 29287935
J Natl Cancer Inst. 2012 Jun 6;104(11):869-83
pubmed: 22393207
Epidemiology. 2012 Jan;23(1):53-4
pubmed: 22157303
ISRN Oncol. 2012;2012:614198
pubmed: 23193486
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Bull World Health Organ. 2014 Sep 1;92(9):672-9
pubmed: 25378758
BMC Cancer. 2017 Aug 30;17(1):596
pubmed: 28854969
Am J Prev Med. 2014 Mar;46(3 Suppl 1):S7-15
pubmed: 24512933
Environ Res. 2017 Jul;156:63-73
pubmed: 28319819
Ann Oncol. 2006 Dec;17(12):1842-7
pubmed: 16971668
Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1729-35
pubmed: 15533900
Ann Ist Super Sanita. 2014;50(2):186-91
pubmed: 24968919
J Occup Environ Med. 2011 May;53(5):522-9
pubmed: 21494158
Environ Int. 2010 Oct;36(7):746-53
pubmed: 20576291
Sci Total Environ. 2002 Mar 8;286(1-3):73-81
pubmed: 11886100
Eur J Epidemiol. 2004;19(1):49-54
pubmed: 15012022
Environ Sci Pollut Res Int. 2018 May;25(13):13067-13078
pubmed: 29484620
Sci Total Environ. 2012 Dec 15;441:265-76
pubmed: 23147397
BMC Public Health. 2012 Aug 01;12:589
pubmed: 22852770
Sci Total Environ. 1997 Jun 20;199(1-2):49-63
pubmed: 9200847
Arch Environ Health. 1996 Jul-Aug;51(4):255-65
pubmed: 8757405
Environ Pollut. 2016 Jul;214:394-399
pubmed: 27108043
Crit Rev Toxicol. 2012 Aug;42(7):549-98
pubmed: 22656672
Int J Occup Med Environ Health. 2011 Dec;24(4):327-38
pubmed: 22002323
Ann Occup Environ Med. 2016 Mar 09;28:11
pubmed: 26962458
Environ Health Perspect. 2009 Aug;117(8):1265-71
pubmed: 19672407
Med Lav. 2019 Feb 22;110(1):3-10
pubmed: 30794243
J Environ Public Health. 2013;2013:939267
pubmed: 23853611
Ann Ist Super Sanita. 2011;47(2):192-9
pubmed: 21709389
Eur J Public Health. 2011 Jun;21(3):376-80
pubmed: 20237172
Lancet Oncol. 2013 Dec;14(13):1262-3
pubmed: 25035875
Environ Health. 2017 Sep 26;16(1):101
pubmed: 28950871
Popul Health Metr. 2009 Jun 28;7:10
pubmed: 19558714
J Radiat Res. 2018 Mar 1;59(2):149-163
pubmed: 29186473
J Natl Cancer Inst. 2012 Jun 6;104(11):855-68
pubmed: 22393209
Occup Med (Lond). 2014 Oct;64(7):539-45
pubmed: 25082833
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Am J Epidemiol. 2000 Jul 1;152(1):32-40
pubmed: 10901327
Environ Health Perspect. 2008 Aug;116(8):1098-104
pubmed: 18709174
Environ Health Perspect. 1996 May;104 Suppl 3:539-41
pubmed: 8781379
Ann Occup Environ Med. 2016 Mar 25;28:15
pubmed: 27019716
Int J Environ Res Public Health. 2018 Feb 02;15(2):
pubmed: 29393920

Auteurs

Jane Idavain (J)

Institute of Family Medicine and Public Health, Faculty of Medicine, University of Tartu, Ravila 19, 50411 Tartu, Estonia.
Department of Health Statistics, National Institute for Health Development, Hiiu 42, 11619 Tallinn, Estonia.

Katrin Lang (K)

Institute of Family Medicine and Public Health, Faculty of Medicine, University of Tartu, Ravila 19, 50411 Tartu, Estonia.

Jelena Tomasova (J)

Estonian Health Board, Paldiski mnt 81, 10617 Tallinn, Estonia.

Aavo Lang (A)

Institute of Biomedicine and Translational Medicine, Faculty of Medicine, University of Tartu, Ravila 19, 50411 Tartu, Estonia.

Hans Orru (H)

Institute of Family Medicine and Public Health, Faculty of Medicine, University of Tartu, Ravila 19, 50411 Tartu, Estonia.
Department of Public Health and Clinical Medicine, Umea University, SE-901 87 Umea, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH